Literature DB >> 1827485

Cytokine production by mature and immature thymocytes.

M Fischer1, I MacNeil, T Suda, J E Cupp, K Shortman, A Zlotnik.   

Abstract

We have studied the ability of subpopulations of activated thymocytes to produce four cytokines (IL-2, IL-4, IFN-gamma and TNF-alpha) which are believed to play roles in T cell development. Supernatants from various thymocyte subsets activated with calcium ionophore and PMA were tested for these cytokines. All CD3hi thymocyte subsets (CD4+8-, CD4-8- and CD4-8+) produced high titers of these four cytokines except CD3+4-8+ thymocytes, which did not produce IL-4. In contrast, CD4+8+ thymocytes did not produce any detectable cytokines. CD3-4-8- thymocytes produced IL-2, IFN-gamma, and TNF-alpha (but not IL-4) when activated by calcium ionophore + PMA and IL-1. We then separated CD3-4-8- thymocytes into IL-2R+ and IL-2R-. CD3-4-8-IL-2R+ thymocytes only produced small amounts of IL-2 when activated with calcium ionophore + PMA + IL-1, whereas CD3-4-8-IL-2R- thymocytes did not require IL-1 to produce IL-2, IFN-gamma, and TNF-alpha. Finally, CD4-8+3- thymocytes (an immature population believed to be an intermediate between CD3-4-8- and CD4+8+ thymocytes) only produced marginally detectable levels of IL-2 upon stimulation with calcium ionophore, PMA, and the addition of IL-1 did not result in increased levels of cytokine production. These observations indicate discrete patterns of cytokine production by the subsets studied and suggest specific controls of cytokine gene expression during T cell development.

Entities:  

Mesh:

Substances:

Year:  1991        PMID: 1827485

Source DB:  PubMed          Journal:  J Immunol        ISSN: 0022-1767            Impact factor:   5.422


  11 in total

1.  Regulation of AP-1 and NFAT transcription factors during thymic selection of T cells.

Authors:  M Rincon; R A Flavell
Journal:  Mol Cell Biol       Date:  1996-03       Impact factor: 4.272

2.  In vivo expression of interleukin-1 beta (IL-1 beta), IL-2, IL-4, IL-6, tumour necrosis factor-alpha and interferon-gamma in the fetal murine thymus.

Authors:  J Deman; M Van Meurs; E Claassen; C Humblet; J Boniver; M P Defresne
Journal:  Immunology       Date:  1996-09       Impact factor: 7.397

3.  Perturbation of the T lymphocyte lineage in transgenic mice expressing a constitutive repressor of nuclear factor (NF)-kappaB.

Authors:  M R Boothby; A L Mora; D C Scherer; J A Brockman; D W Ballard
Journal:  J Exp Med       Date:  1997-06-02       Impact factor: 14.307

4.  High-level replication of human immunodeficiency virus in thymocytes requires NF-kappaB activation through interaction with thymic epithelial cells.

Authors:  L Chêne; M T Nugeyre; F Barré-Sinoussi; N Israël
Journal:  J Virol       Date:  1999-03       Impact factor: 5.103

5.  Differential effect of tumour necrosis factor on human thymocyte subpopulations.

Authors:  M A Muñoz-Fernández; F X Pimentel-Muiños; A González; F Gambon; L Alvarez-Vallina; M Fresno
Journal:  Immunology       Date:  1992-07       Impact factor: 7.397

6.  Expression of cytokines and their receptors by human thymocytes and thymic stromal cells.

Authors:  S S Wolf; A Cohen
Journal:  Immunology       Date:  1992-11       Impact factor: 7.397

7.  Molecular basis for developmental changes in interleukin-2 gene inducibility.

Authors:  D Chen; E V Rothenberg
Journal:  Mol Cell Biol       Date:  1993-01       Impact factor: 4.272

8.  Production of an early release, M(r) 36,000 monokine by stimulated rat macrophages.

Authors:  N M Hedberg; N Hunter; C Soussou; A E Knop
Journal:  Immunology       Date:  1993-11       Impact factor: 7.397

9.  RORgamma t, a novel isoform of an orphan receptor, negatively regulates Fas ligand expression and IL-2 production in T cells.

Authors:  Y W He; M L Deftos; E W Ojala; M J Bevan
Journal:  Immunity       Date:  1998-12       Impact factor: 31.745

Review 10.  The role of orphan nuclear receptor in thymocyte differentiation and lymphoid organ development.

Authors:  Y W He
Journal:  Immunol Res       Date:  2000       Impact factor: 4.505

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.